Brown, Lisle/Cummings’s Fresenius Medical Care FMS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$9.47K Hold
419
﹤0.01% 612
2026
Q1
$9.45K Hold
419
﹤0.01% 587
2025
Q4
$9.98K Hold
419
﹤0.01% 501
2025
Q3
$11K Hold
419
﹤0.01% 492
2025
Q2
$12K Hold
419
﹤0.01% 482
2025
Q1
$10.4K Hold
419
﹤0.01% 491
2024
Q4
$9.49K Buy
+419
New +$9.1K ﹤0.01% 487

Other funds holding FMS

Brown, Lisle/Cummings's FMS Position: Q2 2026 in Review

Brown, Lisle/Cummings held its Fresenius Medical Care (FMS) position steady in Q2 2026 at 419 shares worth $9.47K. The position accounts for ﹤0.01% of the portfolio, ranked #612.

Brown, Lisle/Cummings first reported a position in FMS in Q4 2024 and has held it in 7 quarters since. The position peaked at $12K in Q2 2025. 235 funds tracked by Wall St. Rank hold FMS as of Q2 2026.

  • Brown, Lisle/Cummings held 419 shares of Fresenius Medical Care worth $9.47K as of Q2 2026.
  • Brown, Lisle/Cummings left its Fresenius Medical Care share count unchanged in Q2 2026.
  • Fresenius Medical Care made up ﹤0.01% of Brown, Lisle/Cummings's portfolio in Q2 2026, its #612 holding.
  • Brown, Lisle/Cummings first reported a position in Fresenius Medical Care in Q4 2024 and has held it in 7 quarters since.
  • Brown, Lisle/Cummings's Fresenius Medical Care position peaked at $12K in Q2 2025.
  • 235 funds tracked by Wall St. Rank held Fresenius Medical Care as of Q2 2026.

Based on Brown, Lisle/Cummings's 13F filing for Q2 2026, filed 2 Sep 2026.